A study to evaluate the effect of repeat oral doses of odiparcil on cardiac conduction as assessed by 12-lead electrocardiogram compared to placebo and a single oral dose of moxifloxacin.

Trial Profile

A study to evaluate the effect of repeat oral doses of odiparcil on cardiac conduction as assessed by 12-lead electrocardiogram compared to placebo and a single oral dose of moxifloxacin.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs Moxifloxacin; Odiparcil
  • Indications Acute exacerbations of chronic bronchitis; Acute sinusitis; Bacterial infections; Community-acquired pneumonia; Embolism and thrombosis; Intra-abdominal infections; Respiratory tract infections; Skin and soft tissue infections; Tuberculosis
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 23 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top